Boston Scientific closes purchase of Axonics
MLex Summary: Medical technology developer Boston Scientific has closed its $3.7 billion acquisition of Axonics, a medical device maker that specializes in addressing bowel and urologic disorders, according to a press...To view the full article, register now.
Already a subscriber? Click here to view full article